Management of ErbB2-positive Breast Cancer: Insights from Preclinical and Clinical Studies with Lapatinib

The management of human epidermal growth factor receptor 2-positive (ErbB2+) breast cancer is challenging; patients with ErbB2+ breast tumors have more aggressive disease and a poor prognosis. The increasing incidence of breast cancer in Asia and the limitations of existing treatments pose additiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogel, Charles, Chan, Arlene, Gril, Brunilde, Kim, Sung-Bae, Kurebayashi, Junichi, Liu, Li, Lu, Yen-Shen, Moon, Hanlim
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964177/
https://www.ncbi.nlm.nih.gov/pubmed/20542996
http://dx.doi.org/10.1093/jjco/hyq084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964177/
https://www.ncbi.nlm.nih.gov/pubmed/20542996
http://dx.doi.org/10.1093/jjco/hyq084

Ejemplares similares